Bayer acquires Chinese consumer co.

Share this article:

Bayer announced that it will buy China-based Dihon Pharmaceutical Group, a consumer-care company. The company is known for selling dandruff treatment Kang Wang and antifungal cream Pi Kang Wang.

"Adding the strong OTC brands from Dihon to our portfolio will significantly advance our business in China and positions us well for future growth," said Bayer Healthcare CEO Olivier Brandicourt.

Dihon employs more than 2,000 workers and operates a production and warehouse facility in Kunming.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.